drugset / Trial / NCT02244151

Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval

NCT02244151

Phase 2 Completed 130 enrolled La Fe Health Research Institute
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to determine what is the best time interval between GnRH agonist (triptorelin acetate) ovulation induction allowing for the higher number of mature oocytes (MII) collected in IVF cycles.

Timeline

Start
2014-09
Primary completion
2018-02-01
Completion
2018-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 0.2 mg